700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Research Article Open Access
Prolong labor contributes to increased perinatal and maternal morbidity and also increases the chances of C-section. Pain during labor increase exhaustion and psychological burden to mother. Tramadol is a good analgesic with good pain relief and without significant maternal or fetal adverse effects. This study has done to compare the efficacy of tramadol intramuscular injection among primigravida and multigravida and the number of Top ups of Tramadol required. 100 patients were taken up for study. Of these 100 patients both primipara & multipara were included about 50 each. All patients are in gestational age 37-42 weeks. This is a prospective study conducted in private hospital with patients consent as randomized study. Both fetal and maternal side effects are very minimal. Tramadol reduced the duration of labor in all stages, more in multigravida. Pain relief was better in multigravida than primigravida which is significant. Side effects were minimal with tramadol, almost same in primigravida and multigravida. Tramadol reduced the LSCS deliveries. More multigravida underwent spontaneous vaginal deliveries when compared to primigravida. Tramadol is a better analgesic to reduce labor pain and lesser materno-fetal side effects. Tramadol works more efficiently in multigravida than in primigravida. Both primigravida and multigravida respond better with tramadol as a labor analgesia.
To read the full article Peer-reviewed Article PDF
Author(s): M Suguna Shobha Rani1, K Vara Prasad